{
    "root": "e702be26-651e-4d4a-9d79-4df9f53821c9",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Dextrose",
    "value": "20200227",
    "ingredients": [
        {
            "name": "DEXTROSE MONOHYDRATE",
            "code": "LX22YL083G",
            "drugbank_id": "https://go.drugbank.com/drugs/DB15198"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        }
    ],
    "indications": {
        "text": "dextrose injection indicated source water calories may also used diluent reconstitution powdered liquid ( 10 ml ) product packaged vial 20 mm closure .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "\u2022 intravenous infusion . ( 2.1 ) \u2022 full prescribing information information preparation , , dosing considerations instructions . ( 2.1 , 2.2 , 2.3 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "dextrose injection 5 % , usp clear , sterile solutions dextrose supplied single-dose , partial-fill flexible containers . product description size code ndc dextrose injection 5 % , usp ( 0.05 grams/ml ) 50 ml 2b0040 0338-0551-11 100 ml 2b0041 0338-0551-18 remove container overwrap intended . product immediately mixing introduction additives . exposure pharmaceutical products heat minimized . avoid excessive heat . recommended product stored room temperature ( 25\u00b0c/77\u00b0f ) .",
    "adverseReactions": "dextrose injection contraindicated patients : \u2022 clinically significant hyperglycemia [ ( 5.1 ) ] . \u2022 known hypersensitivity dextrose [ ( 5.2 ) ]",
    "indications_original": "Dextrose Injection is indicated as source of water and calories and may also be used as diluent for reconstitution of a powdered or liquid (up to 10 mL) drug product packaged in a vial with a 20 mm closure.",
    "contraindications_original": "\u2022 Only for intravenous infusion. ( 2.1 ) \u2022 See full prescribing information for information on preparation, administration, dosing considerations and instructions for use. ( 2.1 , 2.2 , 2.3 )",
    "warningsAndPrecautions_original": "Dextrose Injection 5%, USP is a clear, sterile solutions of dextrose supplied in single-dose, partial-fill flexible containers. \n                  \n                     \n                     \n                     \n                     \n                     \n                        \n                           \n                              \n                                 Product Description\n                              \n                           \n                           \n                              \n                                 Size\n                              \n                           \n                           \n                              \n                                 Code\n                              \n                           \n                           \n                              \n                                 NDC\n                              \n                           \n                        \n                        \n                           \n                              Dextrose Injection 5%, USP(0.05 grams/mL) \n                           \n                           \n                              50 mL\n                           \n                           \n                              2B0040\n                           \n                           \n                              0338-0551-11\n                           \n                        \n                        \n                           \n                              100 mL\n                           \n                           \n                              2B0041\n                           \n                           \n                              0338-0551-18\n                           \n                        \n                     \n                  \n                  Do not remove container from the overwrap until intended for use.\n                  Use the product immediately after mixing and the introduction of additives.\n                  Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is recommended the product be stored at room temperature (25\u00b0C/77\u00b0F).",
    "adverseReactions_original": "The use of Dextrose Injection is contraindicated in patients with:\n                  \n                  \n                     \n                        \u2022\n                        Clinically significant hyperglycemia [see \n                        \n                        \n                           \n                              Warnings and Precautions (5.1)\n                           \n                        \n                        \n                           ].\n                        \n                     \n                     \n                        \u2022\n                        Known hypersensitivity to dextrose [see \n                        \n                        \n                           \n                              Warnings and Precautions (5.2)\n                           \n                        \n                        \n                           ]",
    "drug": [
        {
            "name": "Dextrose",
            "drugbank_id": "https://go.drugbank.com/drugs/DB13560"
        }
    ]
}